ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 수면제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다.
성장 예측은 개인화 치료 접근법에 대한 관심 증가, 수면 관련 연구에 대한 투자 증가, 디지털 건강 도구를 통한 인지도 향상, 허브 및 자연 수면 치료제의 인기 증가, 수면 무호흡 증후군 및 기타 관련 질병의 이환율 증가로 촉진됩니다. 앞으로의 주요 동향으로는 약물전달 시스템의 혁신, 서방형 제제의 개량, 수면 추적을 위한 웨어러블 기술의 출현, 인지 행동 치료를 포함한 디지털 툴, 수면장애를 대상으로 한 병용 요법의 창출 등을 들 수 있습니다.
정신질환의 유병률 증가는 향후 수년간 수면제 시장의 성장을 견인할 것으로 예측됩니다. 수면제는 이러한 상태에서는 종종 손상되는 수면의 질을 개선함으로써 정신질환 관리에 중요한 역할을 합니다. 2022년 National Institute of Mental Health의 보고에 의하면, 미국의 18세 이상의 성인 5,930만명이 정신 질환을 경험하고 있으며, 이것은 성인 총 인구의 23.1%에 상당합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 수면제 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 수면제 시장 : 성장률 분석
세계의 수면제 시장 실적 : 규모와 성장, 2019-2024년
세계의 수면제 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 수면제 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 수면약 시장 : 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
처방약
일반의약품(OTC)
세계의 수면약 시장 : 수면장애 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
불면증
수면 무호흡 증후군
하지불안증후군
기면증
몽유병
기타 수면장애
세계의 수면약 시장 : 약제 클래스별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
벤조디아제핀
항우울제
항히스타민제
진정성 항정신병제
기타 약물 클래스
세계의 수면제 시장 : 유통 채널별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원 약국
온라인 약국
소매 약국
세계 수면제 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
재택 케어
전문센터
기타 최종 사용자
세계의 수면약 시장 : 처방약 유형별 세분화 : 분석과 예측, 2019-2024년, 2024-2029F, 2034F
벤조디아제핀
비벤조디아제핀계 수면제
멜라토닌 수용체 작용제
오렉신 수용체 길항제
항우울제
항정신병제
항히스타민제
세계의 수면약 시장 : OTC약 유형별 세분화 : 분석과 예측, 2019-2024년, 2024-2029F, 2034F
항히스타민제
멜라토닌 보충제
허브 보충제
영양보조식품
동종 요법 치료
제7장 지역별/국가별 분석
세계의 수면약 시장 : 지역별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 수면약 시장 : 국가별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
수면제 시장 : 경쟁 구도
수면제 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Limited
Eisai Co. Ltd.
Sun Pharmaceutical Industries Limited
Perrigo Company plc
H. Lundbeck A/S
Aurobindo Pharma Limited
Dr. Reddy's Laboratories Limited
Cipla Limited
Lupin Limited
Zydus Lifesciences Limited
Torrent Pharmaceuticals Limited
Alembic Pharmaceuticals Limited
Vanda Pharmaceuticals Inc.
Natrol LLC
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
수면약 시장(2029년) : 새로운 기회를 제공하는 국가
수면제 시장(2029년) : 새로운 기회를 제공하는 부문
수면제 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Sleep medication refers to drugs specifically formulated to assist individuals in falling asleep more quickly, staying asleep longer, or enhancing the overall quality of their sleep. These medications are primarily used to manage sleep disorders such as insomnia by helping regulate the body's natural sleep-wake cycle.
Sleep medications are broadly categorized into prescription drugs and over-the-counter (OTC) options. Prescription drugs require authorization from a medical professional due to their strength, possible side effects, and the necessity for supervision. Sleep disorders addressed by these medications include insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleepwalking, among others. These medications are further classified into categories such as benzodiazepines, antidepressants, antihistamines, sedating antipsychotics, and others. They are distributed through hospital pharmacies, online platforms, and retail pharmacies, catering to key end-users including hospitals, homecare settings, specialty centers, and others.
The sleep medication market research report is one of a series of new reports from The Business Research Company that provides sleep medication market statistics, including the sleep medication industry global market size, regional shares, competitors with the sleep medication market share, detailed sleep medication market segments, market trends, and opportunities, and any further data you may need to thrive in the sleep medication industry. This sleep medication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The sleep medication market size has grown strongly in recent years. It will grow from $23.94 billion in 2024 to $25.92 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%.
Key factors driving historical growth include the increasing reliance on prescription sleep aids, a surge in chronic diseases that interfere with sleep, rising mental health concerns, a growing preference for OTC sleep products, and the expanding use of digital health and telemedicine services.
The sleep medication market size is expected to see strong growth in the next few years. It will grow to $35.30 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%.
Forecasted growth will be fueled by a growing interest in personalized treatment approaches, heightened investments in sleep-related research, enhanced awareness via digital health tools, increasing popularity of herbal and natural sleep remedies, and a rising incidence of sleep apnea and other associated conditions. Key upcoming trends include innovation in drug delivery systems, improvements in sustained-release formulations, the emergence of wearable technologies for sleep tracking, digital tools incorporating cognitive behavioral therapy, and the creation of combination therapies targeting sleep disorders.
The increasing prevalence of mental illness is expected to drive the growth of the sleep medication market in the coming years. Mental illness encompasses a variety of mental health conditions that affect mood, cognition, behavior, and overall daily functioning. A significant contributor to the rise in mental illness is chronic stress, which can impair brain function and exacerbate mental health disorders. Sleep medications play a crucial role in managing mental illness by improving sleep quality, which is frequently compromised in these conditions. These medications help regulate the sleep-wake cycle, alleviate symptoms such as insomnia and anxiety, and improve overall mental and functional health. For example, in 2022, the National Institute of Mental Health reported that 59.3 million adults aged 18 and older in the United States experienced mental illness, representing 23.1% of the total adult population. This growing incidence of mental illness is thus fueling the expansion of the sleep medication market.
Companies in the sleep medication market are increasingly developing innovative solutions, such as dual orexin receptor antagonists (DORAs), to provide more targeted treatments for insomnia with fewer side effects and a lower risk of dependence. DORAs work by inhibiting the activity of orexin neuropeptides, which are responsible for promoting wakefulness, by blocking both orexin receptors (OX1R and OX2R). This mechanism helps regulate the sleep-wake cycle without directly sedating the brain. For instance, in January 2022, Idorsia Pharmaceuticals Ltd., a pharmaceutical company based in Switzerland, received approval from the U.S. Food and Drug Administration (FDA) for QUVIVIQ (daridorexant) 25 mg and 50 mg. This DORA treatment is intended for adult patients with insomnia and works by blocking wake-promoting orexins to support better sleep regulation.
In July 2024, Cosette Pharmaceuticals Inc., a U.S.-based pharmaceutical company, strengthened its presence in the U.S. sleep medicine market by acquiring Ambien (zolpidem tartrate), a fast-acting sleep medication, and Ambien CR tablets (6.25 mg once daily before bedtime) from Sanofi S.A. for an undisclosed amount. This acquisition adds well-established insomnia treatments to Cosette's portfolio. Sanofi S.A., headquartered in France, is a pharmaceutical company known for its development of sleep medications.
Major players in the sleep medication market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Perrigo Company plc, H. Lundbeck A/S, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Vanda Pharmaceuticals Inc., Natrol LLC.
North America was the largest region in the sleep medication market in 2024. The regions covered in sleep medication report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the sleep medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sleep medication market consists of sales of hormonal sleep aids, anticonvulsants, cannabinoids, and combination medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sleep Medication Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sleep medication market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for sleep medication ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sleep medication market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Prescription-Based Drugs; Over-The-Counter (OTC) Drugs
2) By Sleep Disorder Type: Insomnia; Sleep Apnea; Restless Legs Syndrome; Narcolepsy; Sleep Walking; Other Sleep Disorders
3) By Drug Class; Benzodiazepines: Antidepressants; Antihistamines; Sedating Antipsychotics; Other Drug Classes
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End-Users: Hospitals; Homecare; Speciality Centres; Other End-Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Sleep Medication Market Characteristics
3. Sleep Medication Market Trends And Strategies
4. Sleep Medication Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Sleep Medication Growth Analysis And Strategic Analysis Framework
5.1. Global Sleep Medication PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Sleep Medication Market Growth Rate Analysis
5.4. Global Sleep Medication Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Sleep Medication Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Sleep Medication Total Addressable Market (TAM)
6. Sleep Medication Market Segmentation
6.1. Global Sleep Medication Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prescription-Based Drugs
Over-The-Counter (OTC) Drugs
6.2. Global Sleep Medication Market, Segmentation By Sleep Disorder Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Insomnia
Sleep Apnea
Restless Legs Syndrome
Narcolepsy
Sleep Walking
Other Sleep Disorders
6.3. Global Sleep Medication Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Benzodiazepines
Antidepressants
Antihistamines
Sedating Antipsychotics
Other Drug Classes
6.4. Global Sleep Medication Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.5. Global Sleep Medication Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Speciality Centres
Other End-Users
6.6. Global Sleep Medication Market, Sub-Segmentation Of Prescription-Based Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Benzodiazepines
Non-Benzodiazepine Hypnotics
Melatonin Receptor Agonists
Orexin Receptor Antagonists
Antidepressants
Antipsychotics
Antihistamines
6.7. Global Sleep Medication Market, Sub-Segmentation Of Over-The-Counter Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamines
Melatonin Supplements
Herbal Supplements
Dietary Supplements
Homeopathic Remedies
7. Sleep Medication Market Regional And Country Analysis
7.1. Global Sleep Medication Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Sleep Medication Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
